Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01767064
Other study ID # USCalifornia
Secondary ID RC4AG039115
Status Active, not recruiting
Phase N/A
First received January 10, 2013
Last updated January 10, 2013
Start date February 2012
Est. completion date February 2013

Study information

Verified date January 2013
Source University of Southern California
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Inappropriate antibiotic prescribing for acute respiratory infections (ARIs) persists despite decades of intervention efforts. Negative outcomes of inappropriate antibiotics include increased costs of care, adverse drug reactions, and rising prevalence of antibiotic-resistant bacteria. To address this public health problem, we apply the principles of commitment and consistency in an effort to influence clinician decision-making through the implementation of a low-cost behavioral "nudge" in the form of a simple public commitment device. Clinicians were asked to post in their exam room a signed letter indicating their commitments to reducing inappropriate antibiotic use for ARIs. Our hypothesis is that clinicians displaying the poster-sized commitment letters will decrease their inappropriate antibiotic prescribing for ARIs as compared to clinicians in the control condition (with no posted letter).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 14
Est. completion date February 2013
Est. primary completion date May 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Medical professionals licensed to provide care and prescribe medications (including antibiotics)

- Treating adult patients (18 years of age and older) from 5 Los Angeles community clinics

Exclusion Criteria:

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Other:
Posted commitment letter


Locations

Country Name City State
United States QueensCare Family Clinics Los Angeles California

Sponsors (3)

Lead Sponsor Collaborator
University of Southern California National Institute on Aging (NIA), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of inappropriate antibiotic prescribing for patients with acute respiratory infections Using data from electronic health records, we will calculate clinician antibiotic prescribing rates for antibiotic-inappropriate ARI diagnoses: acute nasopharyngitis (ICD-9 460.x), acute laryngitis without obstruction (465.8), acute laryngopharyngitis (465.0), acute bronchitis (466.x), acute upper respiratory infections of other multiple sites (465.8), acute upper respiratory infections not otherwise specified (465.9), bronchitis not specified as acute or chronic (490.x), non-streptococcal pharyngitis (462.xx), and influenza with other respiratory manifestations (487.1). To control for temporal trends in antibiotic prescribing and provider-fixed effects, we will fit a logistic mixed effects model that predicts inappropriate antibiotic prescribing as a function of study arm and an indicator for baseline versus intervention period (a difference-in-differences regression). up to 12 months post intervention No
See also
  Status Clinical Trial Phase
Completed NCT01454960 - Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Pilot Study) N/A
Completed NCT01454947 - Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study) N/A